Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Indacaterol dose A; Drug: Indacaterol dose B; Drug: Indacaterol dose C; Drug: Indacaterol dose D; Drug: Placebo; Drug: Salmeterol
Sponsor: Novartis Pharmaceuticals
Recruiting - verified March 2010
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: PT003 MDI; Drug: PT005 MDI; Drug: Placebo MDI; Drug: Tiotropium bromide 18 μg (Spiriva Handihaler®); Drug: Formoterol Fumarate 12 μg (Foradil® Aerolizer®); Drug: PT001 MDI
Sponsor: Pearl Therapeutics, Inc.
Recruiting - verified March 2010
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Aclidinium and Formoterol; Drug: Placebo; Drug: Formoterol; Drug: Aclidinium; Drug: Aclidinium and Formoterol
Sponsors: Almirall, S.A.; Forest Laboratories
Recruiting - verified March 2010
Conditions: Pulmonary Disease, Chronic Obstructive; Bronchitis, Chronic; Emphysema
Intervention: Other: Eccentric exercise training
Sponsors: McGill University; McGill University Health Center
Recruiting - verified December 2009
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: AZD5069
Sponsors: AstraZeneca; Quintiles
Recruiting - verified March 2010
Conditions: Pulmonary Disease, Chronic Obstructive; Disease Exacerbation; Pulmonary Embolism; Prothrombin Fragments
Intervention: Other: CT pulmonary angio, blood tests
Sponsor: Hillel Yaffe Medical Center
Not yet recruiting - verified March 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Placebo; Drug: Tiotropium
Sponsors: Boehringer Ingelheim Pharmaceuticals; Pfizer
Recruiting - verified March 2010
Condition: Insomnia
Intervention: Behavioral: cognitive behavioral therapy for insomnia (CBT-I)
Sponsor: University of Illinois
Recruiting - verified February 2010
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Indacaterol; Drug: Placebo
Sponsor: Novartis
Recruiting - verified February 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Device: placebo; Drug: Fluticasone Furoate (FF)/GW642444 Inhalation Powder
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: SCH 527123; Drug: SCH 527123; Drug: SCH 527123; Drug: SCH 527123; Drug: Placebo; Drug: SCH 527123; Drug: SCH 527123; Drug: SCH 527123; Drug: Placebo
Sponsor: Schering-Plough
Recruiting - verified March 2010
Condition: Chronic Obstructive Pulmonary Disease
Intervention:
Sponsors: University of Washington; Puget Sound Veterans Administration Health Care System; The University of Texas Health Science Center at San Antonio; South Texas Veterans Health Care System
Recruiting - verified February 2010
Conditions: Smoking; Pulmonary Disease, Chronic Obstructive
Intervention: Behavioral: Counseling based on answers to the assessment protocol
Sponsors: Karolinska Institutet; Stockholm County Council, Sweden
Not yet recruiting - verified February 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: simvastatin; Drug: Placebo
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Ciprofloxacin (Cipro InhaIe, BAYQ3939); Drug: Placebo
Sponsor: Bayer
Recruiting - verified February 2010
Conditions: Pulmonary Disease, Chronic Obstructive; Chronic Obstructive Pulmonary Disease
Interventions: Drug: FF Inhalation Powder; Drug: FF/GW642444 Inhalation Powder; Drug: GW642444 Inhalation Powder; Drug: Placebo
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Conditions: Pulmonary Disease, Chronic Obstructive; Chronic Obstructive Pulmonary Disease
Interventions: Drug: FF/GW642444 Inhalation Powder; Drug: Placebo; Drug: FF Inhalation Powder; Drug: GW642444 Inhalation Powder
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: aclidinium bromide/formoterol fumarate combination; Drug: aclidinium bromide/formoterol fumarate combination; Drug: aclidinium bromide; Drug: formoterol fumarate; Drug: placebo
Sponsors: Forest Laboratories; Almirall, S.A.
Recruiting - verified February 2010
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Aclidinium bromide; Drug: Aclidinium bromide; Drug: Placebo
Sponsors: Forest Laboratories; Almirall, S.A.
Recruiting - verified February 2010
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: aclidinium bromide; Drug: aclidinium bromide
Sponsors: Forest Laboratories; Almirall, S.A.
Recruiting - verified February 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Olodaterol (BI1744) Low; Drug: Olodaterol (BI1744) High; Drug: Tiotropium 18 mcg; Drug: Placebo (for Olodatero (BI1744)l); Drug: Placebo (for Tiotropium)
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Olodaterol (BI1744) Low; Drug: Placebo (for olodaterol BI1744); Drug: Placebo (for Tiotropium); Drug: Olodaterol (BI1744) High; Drug: Tiotropium 18 mcg
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: olodaterol (BI 1744) low and placebo; Drug: olodaterol (BI 1744) low and low tio; Drug: olodaterol (BI 1744) high and placebo; Drug: olodaterol (BI 1744) low and medium tio; Drug: olodaterol (BI 1744) low and high tio; Drug: olodaterol (BI 1744) high and low tio; Drug: olodaterol (BI 1744) high and medium tio; Drug: olodaterol (B( 1744) high and high tio
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Olodaterol (BI 1744); Drug: Olodaterol (BI 1744); Drug: Placebo
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Olodaterol (BI 1744); Drug: Olodaterol (BI 1744); Drug: Placebo
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Pulmonary Disease, Chronic Obstructive
Intervention:
Sponsors: Boehringer Ingelheim Pharmaceuticals; Pfizer
Recruiting - verified March 2010
Conditions: Pulmonary Disease, Chronic Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Obstructive Airway Disease; COPD
Interventions: Drug: placebo; Drug: active comparator; Drug: PF-03635659; Drug: PF-03635659; Drug: PF-03635659
Sponsor: Pfizer
Recruiting - verified March 2010
Conditions: Chronic Bronchitis; Emphysema; Pulmonary Disease, Chronic Obstructive
Interventions: Drug: GSK573719 250mcg; Drug: GSK573719 500mcg; Drug: GSK573719 125mcg; Drug: Placebo
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: AZD9668; Drug: Placebo
Sponsor: AstraZeneca
Recruiting - verified February 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: FF/GW642444 Inhalation Powder; Drug: GW642444 Inhalation Powder
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Combivent Respimat; Drug: Combivent CFC-MDI; Drug: Atrovent HFA + Albuterol HFA
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: GW642444 Inhalation Powder; Drug: FF/GW642444 Inhalation Powder
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: COPD
Intervention: Drug: R7103
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Pulmonary Disease, Chronic Obstructive
Intervention:
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Aclidinium bromide; Drug: Placebo
Sponsors: Almirall, S.A.; Forest Laboratories
Recruiting - verified March 2010
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Device: ROX Anastomotic Coupler System (ACS)
Sponsor: ROX Medical, Inc.
Recruiting - verified March 2010
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: SCH 527123; Drug: Placebo
Sponsor: Schering-Plough
Recruiting - verified March 2010
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Fluticasone propionate/salmeterol combination product; Drug: Salmeterol; Drug: Placebo
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Conditions: Asthma; Pulmonary Disease, Chronic Obstructive
Intervention: Other: Empty inhalers
Sponsor: Orion Corporation, Orion Pharma
Recruiting - verified February 2010
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Bronchodilator Agents; Drug: Normal saline; Device: Dead space breathing; Device: Room air breathing
Sponsors: Queen's University; Canadian Lung Association
Not yet recruiting - verified March 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Tiotropium 18mcg daily; Drug: Salmeterol 100mcg daily; Drug: Fluticasone 250mcg daily; Drug: Fluticasone 125mcg daily; Drug: Fluticasone 50mcg daily; Drug: Placebo
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: fentanyl; Drug: normal saline (placebo)
Sponsor: Queen's University
Recruiting - verified March 2010
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Dietary Supplement: Vitamin D (cholecalciferol); Dietary Supplement: Placebo
Sponsor: Minneapolis Veterans Affairs Medical Center
Recruiting - verified February 2010
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Arformoterol; Drug: Placebo
Sponsor: Sepracor, Inc.
Recruiting - verified February 2010
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: tetomilast; Drug: placebo
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Recruiting - verified March 2010
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Indacaterol 150 µg; Drug: Tiotropium
Sponsor: Novartis Pharmaceuticals
Recruiting - verified February 2010
Conditions: Advanced Cancer; Chronic Obstructive Pulmonary Disease (COPD); Restrictive Lung Disease; Congestive Heart Failure; End Stage Liver Disease
Intervention: Behavioral: Training Program Intervention
Sponsors: University of Washington; National Institute of Nursing Research (NINR)
Recruiting - verified February 2010
Condition: Chronic Bronchitis
Interventions: Drug: Avelox (Moxifloxacin, BAY12-8039); Drug: Amoxicillin clavulanic acid
Sponsor: Bayer
Recruiting - verified March 2010
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Tiotropium
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Conditions: Pulmonary Disease, Chronic Obstructive; Emphysema; Bronchitis, Chronic
Intervention:
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified July 2009
Conditions: Chronic Obstructive Pulmonary Disease (COPD); Heart Failure
Interventions: Behavioral: Exercise adherence; Behavioral: Self-management- prevention of illness; Behavioral: Self-management of illness
Sponsor: Department of Veterans Affairs
Recruiting - verified February 2010
Condition: COPD
Intervention: Drug: Theophylline
Sponsors: Ottawa Hospital Research Institute; Ontario Lung Association
Recruiting - verified March 2010
All Categories ... Medical Conditions » ... COPD 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
